Title: Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.
Journal: Journal of medicinal chemistry 20120308
114468-01-8
1620-79-7
455-00-5
383907-17-3
916304-19-3
1204580-76-6
1622-58-8 | 1-Ethyl-1h-benzoimidazol-2-ylamine | AA001ST8 | MFCD00159978
162548-73-4 | 4,6-Difluoro-1-indanone | AA001T5V | MFCD04972815
162936-24-5 | β-D-Ribofuranuronamide, 1-(6-amino-2-iodo-9H-purin-9-yl)-1-deoxy-N-ethyl-2,3-O-(1-methylethylidene)- | AA001TGY
163165-75-1 | 1,3,5-Triazine-2,4-diamine, 6-chloro-N-(ethyl-d5)-N'-(1-methylethyl)- (9CI) | AA001TRG | MFCD00143637
1635-28-5 | 2-(Dimethylamino)pyrimidin-4(1H)-one | AA001U37 | MFCD06202319
1638487-42-9 | 5-(Aminomethyl)-2-fluorobenzonitrile hydrochloride | AA001UD1 | MFCD28125524
16429-44-0 | 5-bromo-3-chlorobenzene-1,2-diamine | AA001UOS | MFCD12028675
164667-55-4 | 4H-Furo[3,2-b]pyrrole-5-carboxylic acid, 2-formyl-, methyl ester | AA001UYC | MFCD08531092
160844-75-7 | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | AA001VC5 | MFCD09833701
161563-79-7 | 6-Methylimidazo[2,1-b]thiazole-5-carbohydrazide | AA001VMD | MFCD03086213
